New combo therapy aims to stop rare Cancer's return

This study tests whether adding a drug called pembrolizumab to a special type of radiation therapy can help prevent mucosal melanoma from returning after surgery. About 20 people with this rare head and neck cancer will receive the combination. The goal is to see if this approach works better than radiation alone.